Equagesic: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m (Protected "Equagesic": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 13: | Line 13: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 17:10, 4 September 2012
Equagesic (Template:PronEng) is a combination drug indicated for short-term pain treatment accompanied by tension and/or anxiety in patients with musculoskeletal disease or tension headache.
Composition
It combines[1]
- aspirin 325mg (for pain relief) and
- meprobamate 200mg (used here as a muscle relaxant).
- In some formulations[2] it is also quoted to contain ethoheptazine, an opioid analgesic.
Problems
Equagesic was discontinued in the UK in 2002, possibly because of more adequate drugs available. Specifically, meprobamate is more toxic than benzodiazepines, which are also useful as a muscle relaxant.
Martial artist Bruce Lee died of cerebral oedema thought to have been a reaction to his taking of Equagesic.